EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Advancements in dengue vaccines: A historical overview and pro-spects for following next-generation candidates

Kai Yan, Lingjing Mao, Jiaming Lan, Zhongdang Xiao

Journal of Microbiology · 2025

DOI: 10.71150/jm.2410018 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Microbiology, 2025. Verfasst von Kai Yan und 3 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Bioelectronics, School of Biological Science and Medical Engineering, Southeast University, Nanjing 210096, P. R. China. Hauptthemen laut MEDLINE: Dengue Vaccines, Dengue, Dengue Virus, Vaccine Development. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 227 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Shanghai Science and technology Innovation action plan, Shanghai "Belt and Road" Joint Laboratory Project, Shanghai “Belt and Road” Joint Laboratory Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dengue, caused by four serotypes of dengue viruses (DENV-1 to DENV-4), is the most prevalent and widely mosquito-borne viral disease affecting humans. Dengue virus (DENV) infection has been reported in over 100 countries, and approximately half of the world's population is now at risk. The paucity of universally licensed DENV vaccines highlights the urgent need to address this public health concern. Action and atten-tion to antibody-dependent enhancement increase the difficulty of vaccine development. With the worsen-ing dengue fever epidemic, Dengvaxia® (CYD-TDV) and Qdenga® (TAK-003) have been approved for use in specific populations in affected areas. However, these vaccines do not provide a balanced immune response to all four DENV serotypes and the vaccination cannot cover all populations. There is still a need to develop a safe, broad-spectrum, and effective vaccine to address the increasing number of dengue cases worldwide. This review provides an overview of the existing DENV vaccines, as well as potential candidates for future studies on DENV vaccine development, and discusses the challenges and possible solutions in the field.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dengue VaccinesDengueDengue VirusVaccine DevelopmentHumansAntibodies, ViralSerogroupAnimals

Stichwörter der Autor:innen

antibody-dependent enhancementdengue virusmosquito-bornevaccine

Substanzen

Dengue VaccinesAntibodies, Viral

Autor:innen und Institutionen

  • State Key Laboratory of Bioelectronics, School of Biological Science and Medical Engineering, Southeast University, Nanjing 210096, P. R. China.
  • CAS Key Laboratory of Molecular Virology & Immunology, Shanghai Institute of Immunity and Infection Chinese Academy of Sciences, Shanghai, P. R. China.
  • University of the Chinese Academy of Sciences, Beijing, P. R. China.

Förderung

  • Shanghai Science and technology Innovation action plan
  • Shanghai "Belt and Road" Joint Laboratory Project
  • Shanghai “Belt and Road” Joint Laboratory Project

Zitieren

APA

Yan, K., Mao, L., Lan, J., & Xiao, Z. (2025). Advancements in dengue vaccines: A historical overview and pro-spects for following next-generation candidates. Journal of Microbiology. https://doi.org/10.71150/jm.2410018

Vancouver

Yan K, Mao L, Lan J, Xiao Z. Advancements in dengue vaccines: A historical overview and pro-spects for following next-generation candidates. Journal of Microbiology. 2025. doi:10.71150/jm.2410018

BibTeX
@article{Yan2025,
  author = {Yan, Kai and Mao, Lingjing and Lan, Jiaming and Xiao, Zhongdang},
  title = {Advancements in dengue vaccines: A historical overview and pro-spects for following next-generation candidates},
  journal = {Journal of Microbiology},
  year = {2025},
  doi = {10.71150/jm.2410018}
}
Kostenlos starten →